Old Web
English
Sign In
Acemap
>
authorDetail
>
Ellen K. Ritchie
Ellen K. Ritchie
Georgetown University
Cytarabine
Medicine
Vosaroxin
Placebo
Myeloid leukemia
3
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of Cytogenetics on Clinical Outcome in Patients with First Relapsed or Refractory Acute Myeloid Leukemia Treated with Vosaroxin Plus Cytarabine Vs Placebo Plus Cytarabine: Results from VALOR
2015
Norbert Vey
Farhad Ravandi
Ellen K. Ritchie
Hamid Sayar
Michael Craig
Robert K. Stuart
Jeffrey E. Lancet
Stephen A. Strickland
Renee Ward
Jennifer A. Smith
Terry A. Crowley
Heinz-August Horst
Arnaud Pigneux
Show All
Source
Cite
Save
Citations (0)
Allogeneic Hematopoietic Cell Transplant in Patients ≥60 Years of Age With First Relapsed or Refractory Acute Myeloid Leukemia After Treatment With Vosaroxin Plus Cytarabine vs Placebo Plus Cytarabine: Results From VALOR
2015
Gary Schiller
Ellen K. Ritchie
Hamid Sayar
Jeffrey E. Lancet
Michael Craig
Norbert Vey
Stephen A. Strickland
Harry P. Erba
Arnaud Pigneux
Heinz-August Horst
Christian Récher
Virginia M. Klimek
Olatoyosi Odenike
Adam Craig
Renee Ward
Jennifer A. Smith
Hagop M. Kantarjian
Robert K. Stuart
Farhad Ravandi
Show All
Source
Cite
Save
Citations (0)
Phase I Study of a Liposomal Carrier (CPX-351) Containing a Synergistic, Fixed Molar Ratio of Cytarabine (Ara-C) and Daunorubicin (DNR) in Advanced Leukemias
2008
Blood
Eric J. Feldman
Jeffrey Lancet
Jonathan E. Kolitz
Ellen K. Ritchie
Alan F. List
Ekatherine Asatiani
Tania J Curcio
Michelle Burton
Marge Fricano
Christine Swenson
Lawrence D Mayer
Arthur C. Louie
Show All
Source
Cite
Save
Citations (7)
1